a buy up before todays close?, page-4

You wonder if these cochrane scientists just got the pip because they didn't get what they wanted.

They seem to be bagging na antivirals in general.

"It may be that shortening symptoms for 21 hours is a good value for money,” Deborah Cohen, BMJ’s investigations editor, said in a telephone interview. “I remain to be convinced. The bottom line is that people need to have access to all the data. They need to be able to do an independent review.”

I don't see any positive spin for relenza considering GSK gave them what they wanted. The anti viral anti vaccine anti everything will be all over this.

Prepare to get tarred with the same brush.